AmplifyBio Partners with Industry Leader in Lipid Nanoparticles (LNPs) to Expand Drug Delivery Capabilities
AmplifyBio, an emerging leader among mRNA discovery, development, and manufacturing service providers, announced today that it has formalized a partnership with Stephen Burgess, Ph.D. (AvaBurg...
Orlance Announces Strategic Collaboration With Product Creation Studio for the Development of the MACH-1 System
This Collaboration is Focused on Advancing the Design of the MACH-1 System, Preparing It for Phase 1 Clinical Trials Orlance, a pioneering Seattle-based biotech company,...
Bespak Confirms Completion of Inhaled and Nasal Drug Delivery Business Separation From Recipharm to Focus on the Transition to Low GWP pMDIs
Spin-out unites three sites to create a leading global CDMO as further significant investments announced at Holmes Chapel site Bespak today announced the completion of...
SingleTimeMicroneedles, CEO Jasdeep Singh, Wins 2024 SXSW Pitch Competition
SingleTimeMicroneedles wins the Food, Nutrition, and Health Category. SingleTimeMicroneedles, Inc., a microneedle drug development and delivery company, was selected as the winner of the Food,...
Health Advance Partners Closes SingleTimeMicroneedles’ Pre-Seed Funding Round
Health Advance Partners Agree to Equity Stake in SingleTimeMicroneedles at a $3.5 Million Valuation Health Advance Partners, a leading healthcare and biotech investment firm, has...
Phoreus Biotech Appoints David Schaefer as CEO to Lead Development of Innovative Drug Delivery Nanocarriers
Phoreus Biotech, an innovator in peptide nanocarriers for drug and vaccine delivery, is proud to announce the appointment of David Schaefer as its new Chief...
SingleTimeMicroneedles, Inc. Selected as Finalist for 2024 SXSW Pitch
SingleTimeMicroneedles to showcase STM Patch in the Food, Nutrition, and Health category SingleTimeMicroneedes, Inc., a microneedle drug development and delivery company has been selected as a...
New Nanocarrier Technology Promises Breakthrough in Delivery of Therapeutic Drugs Through Mucosal Membranes
Research is currently underway to develop Cystic Fibrosis treatmentsOLATHE, KS / ACCESSWIRE / April 14, 2023 / Phoreus Biotech, a leading provider of next-generation peptide...
Lexaria Releases Annual Letter from the CEO
KELOWNA, BC / ACCESSWIRE / January 13, 2023 / Lexaria Bioscience Corp. (Nasdaq:LEXX) (Nasdaq:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms...